PAVmed (PAVM) Payables (2015 - 2025)

PAVmed's Payables history runs 11 years deep, the most recent figure standing at $678000.0 for Q4 2025.

• On a quarterly basis, Payables rose 3.2% year-over-year to $678000.0 in Q4 2025; TTM through Dec 2025 was $678000.0, a 3.2% increase from a year earlier, with the FY2025 full-year figure at $678000.0, up 3.2% from the prior year.
• Payables advanced to $678000.0 in Q4 2025 per PAVM's latest filing, from $342000.0 in the prior quarter.
• Across five years, Payables topped out at $8.2 million in Q1 2022 and bottomed at $342000.0 in Q3 2025.
• The 5-year median for Payables is $1.6 million (2023), against an average of $2.3 million.
• Across the five-year window, Payables jumped 275.0% in 2022 and slumped 84.72% in 2023, its largest moves.
• Year by year, Payables stood at $3.3 million in 2021, then fell by 18.04% to $2.7 million in 2022, then plunged by 33.95% to $1.8 million in 2023, then sank by 63.21% to $657000.0 in 2024, then climbed by 3.2% to $678000.0 in 2025.
• Per Business Quant, the three latest PAVM Payables figures stand at $678000.0 (Q4 2025), $342000.0 (Q3 2025), and $387000.0 (Q2 2025).